Clinical Trial Update: Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 pilot trial evaluating ensifentrine versus placebo delivered by inhaler in hospitalized COVID-19 patients; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Sars-cov-2

Drugs mentioned

• Ensifentrine (ensifentrine)

Snippet

Sponsor: Verona Pharma Inc | Conditions: Coronavirus Infection, Covid-19 | Phase 2 | Status: COMPLETED | Results posted: 2022-09-22